Nuclear iASPP may facilitate prostate cancer progression

One of the major challenges in prostate cancer (PCa) research is the identification of key players that control the progression of primary cancers to invasive and metastatic disease. The majority of metastatic PCa express wild-type p53, whereas loss of p63 expression, a p53 family member, is a commo...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris, E V, Cerundolo, L, Lu, M, Verrill, C, Fritzsche, F, White, M J, Thalmann, G N, ten Donkelaar, C S, Ratnayaka, I, Salter, V, Hamdy, F C, Lu, X, Bryant, R J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649527/
https://www.ncbi.nlm.nih.gov/pubmed/25341046
http://dx.doi.org/10.1038/cddis.2014.442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649527/
https://www.ncbi.nlm.nih.gov/pubmed/25341046
http://dx.doi.org/10.1038/cddis.2014.442

Ejemplares similares